Literature DB >> 7787433

An association between acromegaly and thyroid carcinoma.

C Balkany1, G W Cushing.   

Abstract

Acromegaly has been associated with goiter as well as with benign and malignant tumors. Three cases of thyroid carcinoma in patients with acromegaly had been reported in the literature. We previously reported two additional cases of thyroid carcinoma and now present a third from 100 patients with acromegaly, exceeding the expected prevalence. All three thyroid carcinomas were multifocal, suggesting a generalized promotion toward malignancy. These patients had elevated levels of growth hormone and somatomedin-C [insulin-like growth factor (IGF-1)] at the time of thyroid carcinoma diagnosis. We discuss the role of IGF-1 in both benign and malignant thyroid growth, including the presence of IGF-1 receptors on thyroid cells, stimulation of thyroid cell replication by IGF-1, and paracrine secretion of IGF-1 and its binding proteins by thyroid cells. We propose possible mechanisms for the development of thyroid carcinoma in patients with acromegaly and discuss implications for the physician treating patients with acromegaly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7787433     DOI: 10.1089/thy.1995.5.47

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

1.  Acromegaly and thyroid.

Authors:  Klaus von Werder
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

Review 2.  Complications of acromegaly: thyroid and colon.

Authors:  Amit Tirosh; Ilan Shimon
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  Thyroid cancer is the most common cancer associated with acromegaly.

Authors:  Bennur Esen Gullu; Ozlem Celik; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

4.  Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.

Authors:  M Gasperi; E Martino; L Manetti; M Arosio; S Porretti; G Faglia; S Mariotti; A M Colao; G Lombardi; R Baldelli; F Camanni; A Liuzzi
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 5.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

6.  Adrenal morpho-functional alterations in patients with acromegaly.

Authors:  C Scaroni; R Selice; S Benedini; E De Menis; M Arosio; C Ronchi; M Gasperi; L Manetti; G Arnaldi; B Polenta; M Boscaro; N Albiger; E Martino; F Mantero
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

7.  Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.

Authors:  Serkan Dogan; Aysegul Atmaca; Selcuk Dagdelen; Belkis Erbas; Tomris Erbas
Journal:  Endocrine       Date:  2013-05-14       Impact factor: 3.633

8.  Hemangiopericytoma in the setting of acromegaly.

Authors:  W Jeffrey Elias; Isa M Hussaina; James B Chadduck; John A Jane; Edward R Laws; M Beatriz S Lopes
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

9.  Thyroid diseases in patients with acromegaly.

Authors:  Anna Maria Dąbrowska; Jerzy Stanisław Tarach; Maria Kurowska; Andrzej Nowakowski
Journal:  Arch Med Sci       Date:  2013-08-12       Impact factor: 3.318

10.  The insulin and igf-I pathway in endocrine glands carcinogenesis.

Authors:  Roberta Malaguarnera; Alaide Morcavallo; Antonino Belfiore
Journal:  J Oncol       Date:  2012-08-08       Impact factor: 4.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.